Marlborough

The coronavirus pandemic has been not only a health challenge to hospitals in Central Massachusetts and beyond, but also a financial one. Fortunately for the larger Central Massachusetts hospitals, they came into 2020 with healthy financials.

Marlborough pharmaceutical company Sunovion announced on Monday the commercial launch of KYNMOBI, a drug aimed at treating OFF episodes in patients with Parkinson’s disease.

Marlborough medical technology company Hologic will partner with the Washington, D.C.-based nonprofit Black Women’s Health Imperative on a multi-year project aimed at reducing breast cancer screening disparities for Black women.

The two largest Central Massachusetts cities, Worcester and Framingham, remain in the state's highest-risk category for the coronavirus pandemic, as cases across Massachusetts ticked up at the end of September.

A Marlborough manufacturer of body sculpting products has transitioned to manufacturing N95-equivalent masks.

Marlborough’s Cognoptix, a healthcare company developing a system for early detection of Alzheimer’s disease, announced it has closed on an oversubscribed $2.6 millon Series R financing round.

The unemployment rate in the Worcester area improved to 10.3% in August, down from 14.9% a month earlier, according to new data Wednesday from the U.S. Bureau of Labor Statistics.

Medical test manufacturer Oxford Immunotec, based in the United Kingdom and Marlborough, has received U.S. Food and Drug Administration approval to use its tuberculosis test on children aged two years or older, the company announced on Tuesday.

The U.S. Food and Drug Administration has provided emergency use authorization for Hologic’s Panther Fusion SARS-CoV-2 assay on people who show no symptoms of the coronavirus, the Marlborough medical technology company announced on Monday.

The two largest corporations Central Massachusetts corporations by market capitalization — Boston Scientific and TJX Cos. — did not do too well on a new review of how well companies match their actions with words to be more inclusive of society and less to shareholders.